Jorge Coronel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jorge Coronel has a total of 271 co-authors. Here are the top co-authors by number of shared publications:
Robert H. Gilman
Johns Hopkins University, Baltimore, MD 21205, USA
18 shared publicationsLuz Caviedes
14 shared publications- Jon S. Friedland
Affiliation Institute for Infection & Immunity, City St. George’s, University of London, London, United Kingdom
13 shared publications - David A. J. Moore
London School of Hygiene and Tropical Medicine, London, United Kingdom
11 shared publications David A. J. Moore
Laboratorio de Investigación en Enfermedades Infecciosas, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia
9 shared publications- Carlton Aw Evans
IFHAD: Innovation For Health And Development
7 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Synthesis, Antitubercular Activity, and Computational Characterization of Novel Phenylpyrazole‐Isoniazid Derivatives
Six new phenyl‐1 H ‐pyrazole‐carbaldehyde isonicotinylhydrazone derivatives 1-10 were synthesized and characterized by spectroscopic (FT‐IR, 1H NMR, and 13C NMR) techniques and electrospray ionization–mass spectrometry (ESI–MS). Homonuclear data from 2D‐NMR ( 1 H‐ 1 H NOESY) revealed that 3 and 5 adopt the transE isomeric form. The in vitro antitubercular activity of all the synthesized compounds was determined against Mycobacterium tuberculosis (sensitive H37RV and resistant TB DM97). With respect to the isoniazid (INH) standard drug (MIC = 0.91 μM), all the prepared compounds showed greater antitubercular activity with MIC values in the range of 0.38–0.82 μM against Mtb H37Rv‐sensitive strain. However, the preliminary results indicated that Compounds 1 – 10 tested against the TB DM97‐resistant strain showed low bioactivity. The optimized geometry of Compounds 1 – 10 has been determined by density functional theory (DFT) calculations. For Compounds 1 – 6 , the most stable isomers (in DMSO) exhibited an E geometrical configuration, while Compounds 7–10 exhibited a Z configuration. The global reactivity values indicate that Compounds 1 – 10 are slightly more reactive and less stable than the standard (INH). Additionally, they exhibit a strong binding capacity to biomolecules, comparable to INH. The MEP map reveals that the negative and positive potential sites are predominantly located on the C=O and HN–NH groups, respectively, similar to those observed for INH. Drug‐likeness and ADME properties were evaluated. All compounds showed adequate ADME properties and are drug‐like. Molecular docking studies (Compounds 1 – 10 ) into the active site of mycobacterial InhA showed an acceptable dissociation constant with improved binding energy (from −6.7 to −8.1 kcal mol −1 ) compared to isoniazid (−5.6 kcal mol −1 ). Molecular dynamics simulations revealed that the molecules cmp3 (3) and cmp5 (5) form stable ternary complexes with InhA through persistent hydrogen bonding and hydrophobic interactions. These compounds showed reduced active‐site fluctuations and superior binding free energies compared to INH. The findings represent a significant advancement in the discovery of potential antitubercular agents.
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Open AccessSynthesis, Antitubercular Activity, and Computational Characterization of Novel Phenylpyrazole‐Isoniazid Derivatives
Six new phenyl‐1 H ‐pyrazole‐carbaldehyde isonicotinylhydrazone derivatives 1-10 were synthesized and characterized by spectroscopic (FT‐IR, 1H NMR, and 13C NMR) techniques and electrospray ionization–mass spectrometry (ESI–MS). Homonuclear data from 2D‐NMR ( 1 H‐ 1 H NOESY) revealed that 3 and 5 adopt the transE isomeric form. The in vitro antitubercular activity of all the synthesized compounds was determined against Mycobacterium tuberculosis (sensitive H37RV and resistant TB DM97). With respect to the isoniazid (INH) standard drug (MIC = 0.91 μM), all the prepared compounds showed greater antitubercular activity with MIC values in the range of 0.38–0.82 μM against Mtb H37Rv‐sensitive strain. However, the preliminary results indicated that Compounds 1 – 10 tested against the TB DM97‐resistant strain showed low bioactivity. The optimized geometry of Compounds 1 – 10 has been determined by density functional theory (DFT) calculations. For Compounds 1 – 6 , the most stable isomers (in DMSO) exhibited an E geometrical configuration, while Compounds 7–10 exhibited a Z configuration. The global reactivity values indicate that Compounds 1 – 10 are slightly more reactive and less stable than the standard (INH). Additionally, they exhibit a strong binding capacity to biomolecules, comparable to INH. The MEP map reveals that the negative and positive potential sites are predominantly located on the C=O and HN–NH groups, respectively, similar to those observed for INH. Drug‐likeness and ADME properties were evaluated. All compounds showed adequate ADME properties and are drug‐like. Molecular docking studies (Compounds 1 – 10 ) into the active site of mycobacterial InhA showed an acceptable dissociation constant with improved binding energy (from −6.7 to −8.1 kcal mol −1 ) compared to isoniazid (−5.6 kcal mol −1 ). Molecular dynamics simulations revealed that the molecules cmp3 (3) and cmp5 (5) form stable ternary complexes with InhA through persistent hydrogen bonding and hydrophobic interactions. These compounds showed reduced active‐site fluctuations and superior binding free energies compared to INH. The findings represent a significant advancement in the discovery of potential antitubercular agents.
- Open Access
- 30 January 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (1) , 2401445
Up-regulated matrix metalloproteinase activity in soil-transmitted helminth–tuberculosis co-infection is associated with increased lung pathology
Tuberculosis (TB) and soil-transmitted helminths (STHs) are major global health concerns, affecting approximately 1.5 billion and 1.8 billion people, respectively [1, 2]. Both are prevalent in poverty-stricken areas, and helminth infections are thought to polarise the immune response towards a type 2 response, possibly increasing susceptibility to TB [3, 4]. A major concern with TB is lung tissue destruction, which leads to high mortality and long-term morbidity [5]. In 2019, new active TB cases resulted in approximately 122 million disability-adjusted life years, with a projected economic cost of nearly USD 1 trillion from TB deaths between 2015 and 2030 [6, 7]. Individuals co-infected with TB and helminths may experience more severe lung damage compared to those with TB alone [8, 9].
- 30 January 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (1) , 2401445
Open AccessUp-regulated matrix metalloproteinase activity in soil-transmitted helminth–tuberculosis co-infection is associated with increased lung pathology
Tuberculosis (TB) and soil-transmitted helminths (STHs) are major global health concerns, affecting approximately 1.5 billion and 1.8 billion people, respectively [1, 2]. Both are prevalent in poverty-stricken areas, and helminth infections are thought to polarise the immune response towards a type 2 response, possibly increasing susceptibility to TB [3, 4]. A major concern with TB is lung tissue destruction, which leads to high mortality and long-term morbidity [5]. In 2019, new active TB cases resulted in approximately 122 million disability-adjusted life years, with a projected economic cost of nearly USD 1 trillion from TB deaths between 2015 and 2030 [6, 7]. Individuals co-infected with TB and helminths may experience more severe lung damage compared to those with TB alone [8, 9].
- Open Access
- 31 October 2021
- Published by Wiley in Journal of Chemistry
- Vol. 2021, 1-14
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity
Eight new phenylisoxazole isoniazid derivatives, 3-(2-fluorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (1), 3-(2-methoxyphenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (2), 3-(2-chlorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (3), 3-(3-clorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (4), 3-(4-bromophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (5), 5-(4-methoxiphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (6), 5-(4-methylphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (7), and 5-(4-clorophenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (8), have been synthesized and characterized by FT-IR, 1H-NMR, 13C-NMR, and mass spectral data. The 2D NMR (1H-1H NOESY) analysis of 1 and 2 confirmed that these compounds in acetone-d6 are in the trans(E) isomeric form. This evidence is supported by computational calculations which were performed for compounds 18, using DFT/B3LYP level with the 6-311++G(d,p) basis set. The in vitro antituberculous activity of all the synthesized compounds was determined against the Mycobacterium tuberculosis standard strains: sensitive H37Rv (ATCC-27294) and resistant TB DM97. All the compounds exhibited moderate bioactivity (MIC=0.340.41μM) with respect to the isoniazid drug (MIC=0.91μM) against the H37Rv sensitive strain. Compounds 6 (X=4-OCH3) and 7 (X=4-CH3) with MIC values of 12.41 and 13.06μM, respectively, were about two times more cytotoxic, compared with isoniazid, against the resistant strain TB DM97.
- 31 October 2021
- Published by Wiley in Journal of Chemistry
- Vol. 2021, 1-14
Open AccessPhenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity
Eight new phenylisoxazole isoniazid derivatives, 3-(2-fluorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (1), 3-(2-methoxyphenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (2), 3-(2-chlorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (3), 3-(3-clorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (4), 3-(4-bromophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (5), 5-(4-methoxiphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (6), 5-(4-methylphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (7), and 5-(4-clorophenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (8), have been synthesized and characterized by FT-IR, 1H-NMR, 13C-NMR, and mass spectral data. The 2D NMR (1H-1H NOESY) analysis of 1 and 2 confirmed that these compounds in acetone-d6 are in the trans(E) isomeric form. This evidence is supported by computational calculations which were performed for compounds 18, using DFT/B3LYP level with the 6-311++G(d,p) basis set. The in vitro antituberculous activity of all the synthesized compounds was determined against the Mycobacterium tuberculosis standard strains: sensitive H37Rv (ATCC-27294) and resistant TB DM97. All the compounds exhibited moderate bioactivity (MIC=0.340.41μM) with respect to the isoniazid drug (MIC=0.91μM) against the H37Rv sensitive strain. Compounds 6 (X=4-OCH3) and 7 (X=4-CH3) with MIC values of 12.41 and 13.06μM, respectively, were about two times more cytotoxic, compared with isoniazid, against the resistant strain TB DM97.
- Open Access
Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture
Background The MODS is an important assay for early diagnosis of tuberculosis and drug susceptibility. MODS is based in the microscopic observation, underneath, of the characteristic cords of Mycobacterium tuberculosis colonies grown in liquid media. An inverted optical microscope is required to observe and interpret MODS cultures. Unfortunately, the cost of commercial inverted microscopes is not affordable in low resource settings in developing countries. Methodology To perform a diagnosis of tuberculosis using the MODS assay, images with modest quality are enough for proper interpretation. Therefore, the use of a high cost commercial inverted optical microscope is not indispensable. In this study, we designed a prototype of an optical inverted microscope created with a 3D printer and based on a smartphone. The system was evaluated by comparison of manual interpretations of 226 TB positive MODS culture images and 207 negative MODS culture images. Significance The prototype resulted in a low-cost inverted optical microscope, with simple functioning, and whose parts have been manufactured using 3D printing techniques. The quality of the images was good enough and achieved a 100% concordance between the manual inspection with the developed microscope, and the standard diagnostics of MODS.
Open AccessLow-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture
Background The MODS is an important assay for early diagnosis of tuberculosis and drug susceptibility. MODS is based in the microscopic observation, underneath, of the characteristic cords of Mycobacterium tuberculosis colonies grown in liquid media. An inverted optical microscope is required to observe and interpret MODS cultures. Unfortunately, the cost of commercial inverted microscopes is not affordable in low resource settings in developing countries. Methodology To perform a diagnosis of tuberculosis using the MODS assay, images with modest quality are enough for proper interpretation. Therefore, the use of a high cost commercial inverted optical microscope is not indispensable. In this study, we designed a prototype of an optical inverted microscope created with a 3D printer and based on a smartphone. The system was evaluated by comparison of manual interpretations of 226 TB positive MODS culture images and 207 negative MODS culture images. Significance The prototype resulted in a low-cost inverted optical microscope, with simple functioning, and whose parts have been manufactured using 3D printing techniques. The quality of the images was good enough and achieved a 100% concordance between the manual inspection with the developed microscope, and the standard diagnostics of MODS.
- Open Access
- 3 August 2018
- Published by Springer Nature in BMC Medicine
- Vol. 16 (1) , 122
Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis
Congregate settings may serve as institutional amplifiers of tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB). We analyze spatial, epidemiological, and pathogen genetic data prospectively collected from neighborhoods surrounding a prison in Lima, Peru, where inmates experience a high risk of MDR-TB, to investigate the risk of spillover into the surrounding community. Using hierarchical Bayesian statistical modeling, we address three questions regarding the MDR-TB risk: (i) Does the excess risk observed among prisoners also extend outside the prison? (ii) If so, what is the magnitude, shape, and spatial range of this spillover effect? (iii) Is there evidence of additional transmission across the region? The region of spillover risk extends for 5.47 km outside of the prison (95% credible interval: 1.38, 9.63 km). Within this spillover region, we find that nine of the 467 non-inmate patients (35 with MDR-TB) have MDR-TB strains that are genetic matches to strains collected from current inmates with MDR-TB, compared to seven out of 1080 patients (89 with MDR-TB) outside the spillover region (p values: 0.022 and 0.008). We also identify eight spatially aggregated genetic clusters of MDR-TB, four within the spillover region, consistent with local transmission among individuals living close to the prison. We demonstrate a clear prison spillover effect in this population, which suggests that interventions in the prison may have benefits that extend to the surrounding community.
- 3 August 2018
- Published by Springer Nature in BMC Medicine
- Vol. 16 (1) , 122
Open AccessInvestigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis
Congregate settings may serve as institutional amplifiers of tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB). We analyze spatial, epidemiological, and pathogen genetic data prospectively collected from neighborhoods surrounding a prison in Lima, Peru, where inmates experience a high risk of MDR-TB, to investigate the risk of spillover into the surrounding community. Using hierarchical Bayesian statistical modeling, we address three questions regarding the MDR-TB risk: (i) Does the excess risk observed among prisoners also extend outside the prison? (ii) If so, what is the magnitude, shape, and spatial range of this spillover effect? (iii) Is there evidence of additional transmission across the region? The region of spillover risk extends for 5.47 km outside of the prison (95% credible interval: 1.38, 9.63 km). Within this spillover region, we find that nine of the 467 non-inmate patients (35 with MDR-TB) have MDR-TB strains that are genetic matches to strains collected from current inmates with MDR-TB, compared to seven out of 1080 patients (89 with MDR-TB) outside the spillover region (p values: 0.022 and 0.008). We also identify eight spatially aggregated genetic clusters of MDR-TB, four within the spillover region, consistent with local transmission among individuals living close to the prison. We demonstrate a clear prison spillover effect in this population, which suggests that interventions in the prison may have benefits that extend to the surrounding community.
- Open Access
- 13 December 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (420)
Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity
The Mycobacterium tuberculosis –specific antigen lipoarabinomannan measured in the urine of HIV-negative, pulmonary TB-infected patients correlates with disease severity.
- 13 December 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (420)
Open AccessUrine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity
The Mycobacterium tuberculosis –specific antigen lipoarabinomannan measured in the urine of HIV-negative, pulmonary TB-infected patients correlates with disease severity.
- 1 July 2017
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 66 (7) , 1023-1026
Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis
We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical Mycobacterium tuberculosis (MTB) isolates from three distinct groups of patients (unselected patients, patients at high risk of drug-resistant TB and HIV-positive patients) in Lima, Peru. These data highlight the challenges of and discriminatory characteristics required for MTB drug susceptibility testing.
- 1 July 2017
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 66 (7) , 1023-1026
Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis
We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical Mycobacterium tuberculosis (MTB) isolates from three distinct groups of patients (unselected patients, patients at high risk of drug-resistant TB and HIV-positive patients) in Lima, Peru. These data highlight the challenges of and discriminatory characteristics required for MTB drug susceptibility testing.
- Open Access
- 25 January 2017
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 64 (9) , 1174-1181
Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis
Cough is the major determinant of tuberculosis transmission. Despite this, there is a paucity of information regarding characteristics of cough frequency throughout the day and in response to tuberculosis therapy. Here we evaluate the circadian cycle of cough, cough frequency risk factors, and the impact of appropriate treatment on cough and bacillary load. We prospectively evaluated human immunodeficiency virus–negative adults (n = 64) with a new diagnosis of culture-proven, drug-susceptible pulmonary tuberculosis immediately prior to treatment and repeatedly until treatment day 62. At each time point, participant cough was recorded (n = 670) and analyzed using the Cayetano Cough Monitor. Consecutive coughs at least 2 seconds apart were counted as separate cough episodes. Sputum samples (n = 426) were tested with microscopic-observation drug susceptibility broth culture, and in culture-positive samples (n = 252), the time to culture positivity was used to estimate bacillary load. The highest cough frequency occurred from 1 pm to 2 pm, and the lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/hour, respectively). Cough frequency was higher among participants who had higher sputum bacillary load (P < .01). Pretreatment median cough episodes/hour was 2.3 (interquartile range [IQR], 1.2–4.1), which at 14 treatment days decreased to 0.48 (IQR, 0.0–1.4) and at the end of the study decreased to 0.18 (IQR, 0.0–0.59) (both reductions P < .001). By 14 treatment days, the probability of culture conversion was 29% (95% confidence interval, 19%–41%). Coughs were most frequent during daytime. Two weeks of appropriate treatment significantly reduced cough frequency and resulted in one-third of participants achieving culture conversion. Thus, treatment by 2 weeks considerably diminishes, but does not eliminate, the potential for airborne tuberculosis transmission.
- 25 January 2017
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 64 (9) , 1174-1181
Open AccessDynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis
Cough is the major determinant of tuberculosis transmission. Despite this, there is a paucity of information regarding characteristics of cough frequency throughout the day and in response to tuberculosis therapy. Here we evaluate the circadian cycle of cough, cough frequency risk factors, and the impact of appropriate treatment on cough and bacillary load. We prospectively evaluated human immunodeficiency virus–negative adults (n = 64) with a new diagnosis of culture-proven, drug-susceptible pulmonary tuberculosis immediately prior to treatment and repeatedly until treatment day 62. At each time point, participant cough was recorded (n = 670) and analyzed using the Cayetano Cough Monitor. Consecutive coughs at least 2 seconds apart were counted as separate cough episodes. Sputum samples (n = 426) were tested with microscopic-observation drug susceptibility broth culture, and in culture-positive samples (n = 252), the time to culture positivity was used to estimate bacillary load. The highest cough frequency occurred from 1 pm to 2 pm, and the lowest from 1 am to 2 am (2.4 vs 1.1 cough episodes/hour, respectively). Cough frequency was higher among participants who had higher sputum bacillary load (P < .01). Pretreatment median cough episodes/hour was 2.3 (interquartile range [IQR], 1.2–4.1), which at 14 treatment days decreased to 0.48 (IQR, 0.0–1.4) and at the end of the study decreased to 0.18 (IQR, 0.0–0.59) (both reductions P < .001). By 14 treatment days, the probability of culture conversion was 29% (95% confidence interval, 19%–41%). Coughs were most frequent during daytime. Two weeks of appropriate treatment significantly reduced cough frequency and resulted in one-third of participants achieving culture conversion. Thus, treatment by 2 weeks considerably diminishes, but does not eliminate, the potential for airborne tuberculosis transmission.
- Open Access
- 7 December 2016
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 95 (6) , 1239-1246
Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection
Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)–positive patients, as these patients are at heightened risk of developing TB. Pyrazinamide (PZA) is a potent drug that effectively sterilizes persistent Mycobacterium tuberculosis bacilli. However, PZA resistance associated with mutations in the nicotinamidase/pyrazinamidase coding gene, pncA, is increasing. A total of 794 patient isolates obtained from four sites in Lima, Peru, underwent spoligotyping and drug resistance testing. In one of these sites, the HIV unit of Hospital Dos de Mayo (HDM), an isolation ward for HIV/TB coinfected patients opened during the study as an infection control intervention: circulating genotypes and drug resistance pre- and postintervention were compared. All other sites cared for HIV-negative outpatients: genotypes and drug resistance rates from these sites were compared with those from HDM. HDM patients showed high concordance between multidrug resistance, PZA resistance according to the Wayne method, the two most common genotypes (spoligotype international type [SIT] 42 of the Latino American-Mediterranean (LAM)-9 clade and SIT 53 of the T1 clade), and the two most common pncA mutations (G145A and A403C). These associations were absent among community isolates. The infection control intervention was associated with 58–92% reductions in TB caused by SIT 42 or SIT 53 genotypes (odds ratio [OR] = 0.420, P = 0.003); multidrug-resistant TB (OR = 0.349, P < 0.001); and PZA-resistant TB (OR = 0.076, P < 0.001). In conclusion, pncA mutation typing, with resistance testing and spoligotyping, was useful in identifying a nosocomial TB outbreak and demonstrating its resolution after implementation of infection control measures.
- 7 December 2016
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 95 (6) , 1239-1246
Open AccessDetecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection
Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)–positive patients, as these patients are at heightened risk of developing TB. Pyrazinamide (PZA) is a potent drug that effectively sterilizes persistent Mycobacterium tuberculosis bacilli. However, PZA resistance associated with mutations in the nicotinamidase/pyrazinamidase coding gene, pncA, is increasing. A total of 794 patient isolates obtained from four sites in Lima, Peru, underwent spoligotyping and drug resistance testing. In one of these sites, the HIV unit of Hospital Dos de Mayo (HDM), an isolation ward for HIV/TB coinfected patients opened during the study as an infection control intervention: circulating genotypes and drug resistance pre- and postintervention were compared. All other sites cared for HIV-negative outpatients: genotypes and drug resistance rates from these sites were compared with those from HDM. HDM patients showed high concordance between multidrug resistance, PZA resistance according to the Wayne method, the two most common genotypes (spoligotype international type [SIT] 42 of the Latino American-Mediterranean (LAM)-9 clade and SIT 53 of the T1 clade), and the two most common pncA mutations (G145A and A403C). These associations were absent among community isolates. The infection control intervention was associated with 58–92% reductions in TB caused by SIT 42 or SIT 53 genotypes (odds ratio [OR] = 0.420, P = 0.003); multidrug-resistant TB (OR = 0.349, P < 0.001); and PZA-resistant TB (OR = 0.076, P < 0.001). In conclusion, pncA mutation typing, with resistance testing and spoligotyping, was useful in identifying a nosocomial TB outbreak and demonstrating its resolution after implementation of infection control measures.